PROLOR Biotech, Inc. (PBTH)

[surf1944]

7:32AM PROLOR Biotech to present new data on its long-acting human growth hormone and long-acting oxyntomodulin at ENDO 2013 (PBTH) 6.15 : Data previously reported by the company confirmed that hGH-CTP appears to be safe and well tolerated and that it has the potential to be administered once-weekly to adults with growth hormone deficiency. The new data provides further information on the 'excellent' safety and tolerability profile of hGH-CTP in a variety of pre-clinical and clinical studies.